Today: 11 June 2026
RTX stock slips ahead of earnings as Airbus flags Pratt & Whitney engine bottlenecks

RTX stock slips ahead of earnings as Airbus flags Pratt & Whitney engine bottlenecks

New York, Jan 26, 2026, 21:28 EST — Market closed.

  • RTX shares dipped 0.9% on Monday as investors awaited results set for release before Tuesday’s open.
  • Airbus flagged persistent delivery issues linked to Pratt & Whitney engines.
  • Options traders are betting on about a 5% move after earnings.

RTX (RTX.N) shares dipped 0.9% to end Monday at $194.13, as investors braced for the aerospace and defense giant’s quarterly earnings report set to drop before the market opens.

The update arrives amid mounting pressure from Airbus, a key Pratt & Whitney customer. Airbus CEO Guillaume Faury highlighted that the planemaker’s “most serious difficulties” lie with Pratt & Whitney engines and rival CFM, intensifying concerns about supply reliability ahead of RTX’s earnings. Reuters

This is key since Pratt & Whitney’s delivery speed and repair volume directly impact cash flow timing and customer payouts, while RTX aims to keep up the pace at its defense unit, Raytheon. Investors often react more to guidance than the actual quarterly results, searching for clues that backlog is converting into revenue.

RTX plans to report its fourth-quarter and full-year 2025 earnings on Tuesday before U.S. markets open, with a conference call set for 8:30 a.m. ET.

Wall Street is looking for earnings near $1.47 per share on roughly $22.7 billion in revenue, based on consensus estimates released Monday.

Signals in the commercial aviation supply chain remain mixed. Embraer’s commercial chief, Arjan Meijer, told Reuters that Pratt & Whitney has “largely overcome shortages and maintenance bottlenecks,” but added the dispute over geared turbofan engines on Airbus jets has intensified. Reuters

The geared turbofan, or GTF, stands as Pratt & Whitney’s flagship narrowbody engine line and remains a focal point for investors due to accelerated inspection demands. RTX had earlier projected it would pull 600 to 700 engines from Airbus A320neo-family planes for extensive checks between 2023 and 2026, linked to a powder-metal problem.

RTX slipped Monday, mirroring losses across major aerospace and defense stocks like Lockheed Martin and Boeing.

Options trading points to a big move in RTX following Tuesday’s earnings, with implied volatility pricing in about a 5% swing. This is a market measure of how much the stock could jump or drop after the report.

But the situation is double-edged. Should RTX signal inspection and compensation costs exceeding expectations, or if engine deliveries and shop visits lag behind customer hopes, the stock might still take a hit despite beating top-line estimates.

Investors are zeroing in on Tuesday’s earnings and, crucially, RTX’s outlook on 2026 cash flow, Pratt & Whitney engine availability, and the speed of the GTF inspection program during the 8:30 a.m. ET call.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Exxon Mobil stock dips after hours as Baytown freeze and carbon-capture launch set up earnings week
Previous Story

Exxon Mobil stock dips after hours as Baytown freeze and carbon-capture launch set up earnings week

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom
Next Story

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom

Go toTop